» Articles » PMID: 2604724

Conformational Analysis of PKI(5-22)amide, the Active Inhibitory Fragment of the Inhibitor Protein of the Cyclic AMP-dependent Protein Kinase

Overview
Journal Biochem J
Specialty Biochemistry
Date 1989 Dec 1
PMID 2604724
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Fourier-transform i.r. spectroscopy, 1H-n.m.r. spectroscopy and X-ray scattering were used to study the conformation and shape of the peptide PKI(5-22)amide, which contains the active site of the inhibitor protein of the cyclic AMP-dependent protein kinase [Cheng, Van Pattern, Smith & Walsh (1985) Biochem. J. 231, 655-661]. The X-ray-scattering solution studies show that the peptide has a compact structure with Rg 0.9 nm (9.0 A) and a linear maximum dimension of 2.5 nm (25A). Compatible with this, Fourier-transform i.r. and n.m.r. determinations indicate that the peptide contains approx. 26% alpha-helix located in the N-terminal one-third of the molecule. This region contains the phenylalanine residue that is one essential recognition determinant for high-affinity binding to the protein kinase catalytic site.

Citing Articles

Role of the αC-β4 loop in protein kinase structure and dynamics.

Wu J, Jonniya N, Hirakis S, Olivieri C, Veglia G, Kornev A Elife. 2024; 12.

PMID: 39630082 PMC: 11616992. DOI: 10.7554/eLife.91980.


Redox Modification of PKA-Cα Differentially Affects Its Substrate Selection.

Delva-Wiley J, Ekhator E, Adams L, Patwardhan S, Dong M, Newman R Life (Basel). 2023; 13(9).

PMID: 37763215 PMC: 10532679. DOI: 10.3390/life13091811.


Protein Kinase Structure and Dynamics: Role of the αC-β4 Loop.

Wu J, Jonniya N, Hirakis S, Olivieri C, Veglia G, Kornev A bioRxiv. 2023; .

PMID: 37693538 PMC: 10491255. DOI: 10.1101/2023.08.31.555822.


Edmond Fischer's kinase legacy: History of the protein kinase inhibitor and protein kinase A.

Taylor S, Herberg F, Veglia G, Wu J IUBMB Life. 2023; 75(4):311-323.

PMID: 36855225 PMC: 10050139. DOI: 10.1002/iub.2714.


Biochemical Analysis of AKAP-Anchored PKA Signaling Complexes.

Byrne D, Omar M, Kennedy E, Eyers P, Scott J Methods Mol Biol. 2022; 2483:297-317.

PMID: 35286684 PMC: 9518671. DOI: 10.1007/978-1-0716-2245-2_19.


References
1.
Walsh D, Ashby C, Gonzalez C, Calkins D, FISCHER E . Krebs EG: Purification and characterization of a protein inhibitor of adenosine 3',5'-monophosphate-dependent protein kinases. J Biol Chem. 1971; 246(7):1977-85. View

2.
Glass D, Lundquist L, Katz B, Walsh D . Protein kinase inhibitor-(6-22)-amide peptide analogs with standard and nonstandard amino acid substitutions for phenylalanine 10. Inhibition of cAMP-dependent protein kinase. J Biol Chem. 1989; 264(24):14579-84. View

3.
Gill G, Holdy K, Walton G, Kanstein C . Purification and characterization of 3':5'-cyclic GMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1976; 73(11):3918-22. PMC: 431265. DOI: 10.1073/pnas.73.11.3918. View

4.
Demaille J, Peters K, FISCHER E . Isolation and properties of the rabbit skeletal muscle protein inhibitor of adenosine 3',5'-monophosphate dependent protein kinases. Biochemistry. 1977; 16(14):3080-6. DOI: 10.1021/bi00633a006. View

5.
Chou P, Fasman G . Empirical predictions of protein conformation. Annu Rev Biochem. 1978; 47:251-76. DOI: 10.1146/annurev.bi.47.070178.001343. View